Zimmer Biomet Holdings, Inc. (ZBH) Q3 2022 Earnings Call Transcript

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q3 2022 Earnings Conference Call November 2, 2022 8:30 AM ET

Company Participants

Keri Mattox - Senior Vice President, Chief Communications & Administration Officer

Bryan Hanson - Chairman, President & Chief Executive Officer

Suky Upadhyay - Executive Vice President & Chief Financial Officer

Ivan Tornos - Chief Operating Officer

Conference Call Participants

Shagun Singh - RBC

Steven Lichtman - Oppenheimer & Company

Vijay Kumar - Evercore ISI

Travis Steed - Bank of America

Robbie Marcus - JPMorgan

Joanne Wuensch - Citibank

Richard Newitter - Truist Securities

Jeff Johnson - Baird

Matthew O'Brien - Piper Sandler

Operator

Good morning, ladies and gentlemen and welcome to the Zimmer Biomet Third Quarter 2022 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded today, November 2, 2022. Following today's presentation, there will be a question-and-answer session. At this time, all participants are in a listen-only mode. [Operator Instructions]

I would now like to turn the conference over to Keri Mattox, Senior Vice President, Chief Communications and Administration Officer. Please, go ahead.

Keri Mattox

Thank you, operator, and good morning, everyone. I hope you are all well and safe. Welcome to Zimmer Biomet's third quarter 2022 earnings conference call. Joining me today are Bryan Hanson, our Chairman, President and CEO; EVP and CFO, Suky Upadhyay; and COO, Ivan Tornos.

Before we get started, I'd like to remind you that our comments during this call will include forward-looking statements. Actual results may differ materially from those indicated by the forward-looking statements due to a variety of risks and uncertainties. Please note we assume no obligation to update these forward-looking statements, even if actual results or future expectations change materially. Please refer to our SEC filings for a detailed discussion of these risks and uncertainties, in addition to the inherent limitations of such forward-looking statements.

Additionally, the discussions on this call will include certain non-GAAP financial measures. Reconciliation of these measures to the most directly comparable GAAP financial measures is included within our Q3 earnings release, which can be found on our website, zimmerbiomet.com.

With that, I'll turn the call over to Bryan. Bryan?

Bryan Hanson

Thanks, Keri, and thanks for joining us for the call this morning. We've got three sections of the call. First, I'm going to briefly talk about our Q3 performance and really the momentum that we saw in Q3 that has allowed us to increase our outlook for the year and doing so, even in the face of some pretty meaningful macro pressures that we're certainly still facing. I also want to spend time talking about our ZB innovation. This is clearly the driver of our continued strong performance and will be the driver as we go forward. And for the second section, Suky will provide more detail on the quarter, but probably more importantly, our 2022 guidance update. And then we'll close things out by addressing any questions you might have.